Chromatin assembly factor 1 suppresses epigenetic reprogramming toward adaptive drug resistance
The long-term effectiveness of targeted cancer therapies is limited by the development of resistance. Although epigenetic reprogramming has been implicated in resistance, the mechanisms remain elusive. Herein, we demonstrate that increased chromatin accessibility is involved in adaptive BRAF inhibit...
Guardado en:
Autores principales: | Zhiquan Wang, Rentian Wu, Qian Nie, Kelly J. Bouchonville, Robert B. Diasio, Steven M. Offer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/accd85a0450f4044aac0532324b3811d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genomic Marks Associated with Chromatin Compartments in the CTCF, RNAPII Loop and Genomic Windows
por: Teresa Szczepińska, et al.
Publicado: (2021) -
Local chromatin fiber folding represses transcription and loop extrusion in quiescent cells
por: Sarah G Swygert, et al.
Publicado: (2021) - Epigenetics & chromatin
-
Linker histone H1.8 inhibits chromatin binding of condensins and DNA topoisomerase II to tune chromosome length and individualization
por: Pavan Choppakatla, et al.
Publicado: (2021) -
Conjunctival Melanoma: Update on Genetics, Epigenetics and Targeted Molecular and Immune-Based Therapies
por: Gkiala A, et al.
Publicado: (2020)